Assignee
GENEIUS BIOTECHNOLOGY INC
US·1 granted patent·9 pending applications·0 citations·filing 2016–2023
Top patents by PatentIndex Score
10 records- 0172US2024189353A1Modulated immunodominance therapyGENEIUS BIOTECHNOLOGY INC·Filed 2023·Application pending·0 cites
- 0257US11723921B2Modulated immunodominance therapyGENEIUS BIOTECHNOLOGY INC·Filed 2017·Granted Aug 15, 2023·0 cites·12 claims
- 0352US2023145991A1T cell compositions for immunotherapyGENEIUS BIOTECHNOLOGY INC·Filed 2022·Application pending·0 cites
- 0448US2017101625A1Modulated immunodominance therapyGENEIUS BIOTECHNOLOGY INC·Filed 2016·Application pending·0 cites
- 0548US2017042998A1Modulated immunodominance therapyGENEIUS BIOTECHNOLOGY INC·Filed 2016·Application pending·0 cites
- 0648US2017042999A1Modulated immunodominance therapyGENEIUS BIOTECHNOLOGY INC·Filed 2016·Application pending·0 cites
- 0748US2017043000A1Modulated immunodominance therapyGENEIUS BIOTECHNOLOGY INC·Filed 2016·Application pending·0 cites
- 0848US2017043001A1Modulated immunodominance therapyGENEIUS BIOTECHNOLOGY INC·Filed 2016·Application pending·0 cites
- 0941US2024000935A1Antigen specific t cells and methods of making and using sameGENEIUS BIOTECHNOLOGY INC·Filed 2021·Application pending·0 cites
- 1039US2020237819A1T cell compositions for immunotherapyGENEIUS BIOTECHNOLOGY INC·Filed 2017·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when GENEIUS BIOTECHNOLOGY INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →